Psychiatry · South Bend, IN
NPI
1588801500
Since 2009
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
415 E Madison St
South Bend, IN, 46617
Phone (574) 533-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
438 services
Medicare patients, 2024
95
Average age 50
Drug cost, 2024
$2.2M
7,494 prescriptions
Company payments, 2025
$4,180
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Platt was code 99214 (office e&m - established), 289 times for 90 patients. In total Michael B Platt billed 438 services in 5 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 289 | 90 | $60.19 | $17K |
| 99211 Office E&M - Established | Office | 138 | 18 | $5.89 | $813 |
By year: 2022 $25K for 507 services; 2023 $22K for 464 services; 2024 $19K for 438 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Platt prescribed most often to Medicare patients was Trazodone Hcl, with 572 prescriptions and refills. In total Michael B Platt wrote 7,494 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 572 | 673 | 81 | $6,326 |
| Clonazepam Generic | 418 | 436 | 56 | $2,868 |
| Alprazolam Generic | 329 | 337 | 35 | $2,469 |
| Buspirone Hcl Generic | 328 | 377 | 46 | $7,820 |
| Sertraline Hcl Generic | 248 | 293 | 31 | $2,566 |
| Prazosin Hcl Generic | 230 | 244 | 26 | $3,857 |
| Fluoxetine Hcl Generic | 223 | 261 | 28 | $1,274 |
| Bupropion Xl Bupropion Hcl | 202 | 261 | 25 | $4,218 |
| Risperidone Generic | 199 | 223 | 23 | $3,688 |
| Aripiprazole Generic | 197 | 257 | 36 | $14K |
| Quetiapine Fumarate Er Quetiapine Fumarate | 177 | 195 | 22 | $32K |
| Lorazepam Generic | 176 | 200 | 30 | $1,751 |
| Invega Sustenna Paliperidone Palmitate | 162 | 162 | 16 | $528K |
| Quetiapine Fumarate Generic | 157 | 205 | 23 | $3,611 |
| Lamotrigine Generic | 154 | 184 | 25 | $1,845 |
Brand drugs: - claims; generic drugs: 6,622 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Platt $4,180 ($4,180 in general payments such as food, travel and fees) from 16 companies. The largest payer was Neurocrine BioSciences, Inc. with $717.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 9 | $717 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $540 |
| Alkermes, Inc. ALKS | 12 | $448 |
| Corium, LLC | 4 | $417 |
| Axsome Therapeutics, Inc. AXSM | 8 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 7 | $310 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 3 | $289 |
| Abbvie Inc. ABBV | 10 | $254 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $245 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $237 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.